dstock - Merck's round the clock construction to finish off its West Point manufacturing facilities is no coincidence. Merck is well aware of the explosion in worldwide cancer rates, and who best to reap the benefits?
Dr. Patrick Soon-Shiong, owner of the LA Times and a renowned transplant surgeon, is raising alarms about the fallout from mRNA COVID-19 “vaccines,” linking them to unprecedented deaths and cancers in children.
“For the first time in my career, I’ve seen an 8-year-old, 9-year-old, and 10-year-old with colon cancer.” “A 13-year-old child died of metastatic pancreatic cancer.”
He has thrown his support behind Robert F. Kennedy Jr., stating Kennedy “knows more about the science than most doctors.”
. The recommended screening age for a colonoscopy has been lowered to 45 from 50. My main point here is this. The Timing of DCVAX's arrival is impeccable, with the current epidemic in cancer rates, there's no time for theoretical phase 1 studies, or 2, if that. Pressure from investors will pale in comparison to the tsunami in demand that's building up. People have no idea, what the hell is going on. I'll leave it there.
dstock, here is a descriptions of a lab at Mainz, Germany, that develops vaccination strategies against tumors.
Research Interests of the Radsak Laboratory The Radsak Lab is part of the Department of Hematology, Oncology, and Pneumology at the University Medical Center of the Johannes Gutenberg-University of Mainz, Germany. In our group we are interested in immunological questions with the aim to improve the treatment of patients with malignancies. In this context we develop novel vaccination strategies against tumors und try to understand the relevant mechanisms here that are required for an optimal anti-tumor response. Another focus is on activation mechanisms of polymorphonuclear neutrophils (PMN) within the innate immune response because immunodeficiency and infections are major side effects of commonly used chemo- or radiotherapies used for the treatment of various malignancies.
Our group is closely associated with the Institute for Immunology, so that we are well embedded in the immunologically interested scientific community on a broad basis.